NeuroVision Imaging

United States
Whitewater, Wisconsin, United States, 95833

Company profile

NeuroVision Imaging company profile

NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trials globally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases.

Business identity

Phone number
9167972340
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2010-01-01, Year

Headquarters

Postal code
95833
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
5
Total equity funding
$21.2M
Last funding
Grant / 2021-08-24
Last equity funding
Series C / $11.2M
Investors
8
Lead investors
2
Founders
4
Articles
11

Founders and investors

Founders

Keith L. BlackMaya Koronyo- HamaouiSteven R. VerdoonerYosef Koronyo

Lead investors

Alzheimer's Drug Discovery FoundationWildcat Capital Management

Investors

Alzheimer's Drug Discovery FoundationJohnson & Johnson InnovationNikon-SBI Innovation FundOmega FundsWildcat Capital Management